Advanced search
Start date
Betweenand

Non-coding RNAs involved with melanoma genesis and progression

Abstract

Melanomas are tumors that may frequently progress to their most aggressive form, the metastatic one, been responsible for more than 80% of deaths caused by all types of skin cancers. Considering that, if not early diagnosed and treated, it can rapidly progress and become fatal, the search for tumor markers in tumor samples and biological fluids has received increased attention. It is estimated that 90% of our genome are transcribed into non-coding RNAs (ncRNAs). NcRNAs, which include the micro RNAs (miRNAs) and long ncRNAs (lncRNAs), are among the frequent molecular alterations found in tumors, like melanomas. The role of lncRNAs has been described in processes such as cell proliferation, differentiation and migration. In addition, recent studies have demonstrated that lncRNAs can regulate the epigenetic machinery, splicing and mRNA stability, besides recruiting transcription factors. miRNAs have regulatory function and control several biological processes, since they bind to target mRNAs and impair their translation. The increased or decreased expression of ncRNAs contribute to the loss of cellular homeostasia and favor the onset of many diseases, include cancer. Besides their roles in tumor biology, studies have demonstrated the potential use of ncRNAs as markers for diagnosis, prediction of response to therapy, and prognosis to monitor disease progression. In this context, based on a linear cellular model of melanoma progression, our aim is to investigate and identify differentially expressed ncRNAs during melanoma progression, elucidate their functional roles in melanoma biology, and evaluate their potential to predict the evolution to metastasis, contributing to therapeutic decision. This study, initially based on a cellular model, will be validated in human melanoma cell lines and exosomes isolated from plasma of patients with primary melanomas, presenting or not metastasis. In addition, analysis of the correlation between the expression of ncRNAs and overall survival will be done using public databases of human melanoma samples. Taken together, this study might contribute to the establishment of novel strategies of prognosis, diagnosis and therapy for melanoma, and also to a better understanding of the role of ncRNAs in melanoma genesis and progression. (AU)

Articles published in Agência FAPESP Newsletter about the research grant:
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
JUSTO, BEATRIZ LAIS; JASIULIONIS, MIRIAM GALVONAS. Characteristics of TIMP1, CD63, and beta 1-Integrin and the Functional Impact of Their Interaction in Cancer. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v. 22, n. 17 SEP 2021. Web of Science Citations: 0.
PESSOA, DIOGO DE OLIVEIRA; RIUS, FLAVIA EICHEMBERGER; ANGELO PAPAIZ, DEBORA D.; PEDROSO AYUB, ANA LUISA; MORAIS, ALICE SANTANA; DE SOUZA, CAMILA FERREIRA; DA PAIXAO, VINICIUS FERREIRA; SETUBAL, JOAO CARLOS; NEWTON-BISHOP, JULIA; NSENGIMANA, JEREMIE; AZEVEDO, HATYLAS; REIS, EDUARDO MORAES; JASIULIONIS, MIRIAM GALVONAS. Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression. Neoplasia, v. 23, n. 4, p. 439-455, APR 2021. Web of Science Citations: 0.
AZEVEDO, HATYLAS; PESSOA, GUILHERME CAVALCANTE; DE LUNA VITORINO, FRANCISCA NATHALIA; NSENGIMANA, JEREMIE; NEWTON-BISHOP, JULIA; REIS, EDUARDO MORAES; DA CUNHA, JULIA PINHEIRO CHAGAS; JASIULIONIS, MIRIAM GALVONAS. Gene co-expression and histone modification signatures are associated with melanoma progression, epithelial-to-mesenchymal transition, and metastasis. CLINICAL EPIGENETICS, v. 12, n. 1 AUG 24 2020. Web of Science Citations: 0.

Please report errors in scientific publications list by writing to: cdi@fapesp.br.